Liquid Biopsies for Cancer

Дата публикации: 10-08-2026 00:00:00

This narrative review examines how liquid biopsy, particularly circulating tumor DNA, can guide treatment decisions by helping clinicians monitor cancer progression, detect minimal residual cancer, and identify genetic sequence variations.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	‘Liquid biopsy’ tech contributes to successful clinical trial for detecting breast cancer recurrence	0	6.61	29-07-2020
2	Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases	0	7	03-07-2026
3	Urinary Biomarkers: Is the Era of Exclusive Follow-Up Cystoscopy Coming to an End? A Mini-Review of Emerging Molecular Diagnostics and Risk-Stratified Surveillance	0	8.06	08-04-2026
4	Exosome-Mediated Communication in The Tumor Microenvironment: Mechanism and Therapeutic Challenges [version 1; peer review: awaiting peer review]	0	14.4	06-08-2026
5	No Difference in DFS Between Post-adjuvant Chemotherapy and Placebo In High-Risk Patients Identified Through ctDNA-based MRD Assessment After CRC Resection	0	5	22-06-2026
6	New blood test for noncoding RNA significantly improves cancer detection	7	8	31-08-2023
7	EPIPREDICT, la revolución de la biopsia líquida para personalizar la inmunoterapia contra el cáncer metastásico	7	8	02-07-2026
8	Выявлены ключевые маркеры для оптимизации индивидуальной терапии рака желудка	0	0	05-06-2025
9	When Not to Push the Boulder	0	5	02-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 8.31. Источник: archderm.jamanetwork.com.